Literature DB >> 21196172

Timing is everything: stochastic origins of cell-to-cell variability in cancer cell death.

Joanna Skommer1, Subhadip Raychaudhuri, Donald Wlodkowic.   

Abstract

The diversity of cell populations is regulated by extracellular and intracellular variability. The latter includes genetic, epigenetic and stochastic variability, all contributing to the experimentally observed heterogeneity in response to external death-inducing stimuli. Studies of sources and regulation of variability in commitment to apoptotic cancer cell death are likely to identify the fundamental features of apoptotic protein networks that are responsible for determining the ultimate cell fate. Systems biology approaches, involving computer simulations of the biochemical reactions accompanied, if possible, by experimental verification of selected components of the model, are proving useful in determining the origins of cell-to-cell variability in response to external stress stimuli. Here we summarize our current understanding of the origins of stochastic variability in cells' commitment to apoptosis, and its implications in the field on cancer therapy.

Entities:  

Mesh:

Year:  2011        PMID: 21196172     DOI: 10.2741/3689

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  11 in total

1.  Apoptosis goes on a chip: advances in the microfluidic analysis of programmed cell death.

Authors:  Donald Wlodkowic; Khashayar Khoshmanesh; John C Sharpe; Zbigniew Darzynkiewicz; Jonathan M Cooper
Journal:  Anal Chem       Date:  2011-06-16       Impact factor: 6.986

2.  Real-time cell viability assays using a new anthracycline derivative DRAQ7®.

Authors:  Jin Akagi; Magdalena Kordon; Hong Zhao; Anna Matuszek; Jurek Dobrucki; Rachel Errington; Paul J Smith; Kazuo Takeda; Zbigniew Darzynkiewicz; Donald Wlodkowic
Journal:  Cytometry A       Date:  2012-11-16       Impact factor: 4.355

3.  Death ligand concentration and the membrane proximal signaling module regulate the type 1/type 2 choice in apoptotic death signaling.

Authors:  Subhadip Raychaudhuri; Somkanya C Raychaudhuri
Journal:  Syst Synth Biol       Date:  2013-09-19

4.  Multivariate analysis of apoptotic markers versus cell cycle phase in living human cancer cells by microfluidic cytometry.

Authors:  Jin Akagi; Joanna Skommer; Anna Matuszek; Kazuo Takeda; Yuu Fujimura; Khashayar Khoshmanesh; Kourosh Kalantar-Zadeh; Arnan Mitchell; Rachel Errington; Paul J Smith; Zbigniew Darzynkiewicz; Donald Wlodkowic
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2013-03-09

5.  Kinetic viability assays using DRAQ7 probe.

Authors:  Donald Wlodkowic; Jin Akagi; Jurek Dobrucki; Rachel Errington; Paul J Smith; Kazuo Takeda; Zbigniew Darzynkiewicz
Journal:  Curr Protoc Cytom       Date:  2013-07

Review 6.  Cytometry of apoptosis. Historical perspective and new advances.

Authors:  D Wlodkowic; J Skommer; Z Darzynkiewicz
Journal:  Exp Oncol       Date:  2012-10

7.  Spatio-temporal analysis of tamoxifen-induced bystander effects in breast cancer cells using microfluidics.

Authors:  Ivan Rios-Mondragon; Xiang Wang; Hans-Hermann Gerdes
Journal:  Biomicrofluidics       Date:  2012-06-08       Impact factor: 2.800

8.  Retinitis pigmentosa: rapid neurodegeneration is governed by slow cell death mechanisms.

Authors:  A Sahaboglu; O Paquet-Durand; J Dietter; K Dengler; S Bernhard-Kurz; P Ar Ekström; B Hitzmann; M Ueffing; F Paquet-Durand
Journal:  Cell Death Dis       Date:  2013-02-07       Impact factor: 8.469

9.  Monte carlo study elucidates the type 1/type 2 choice in apoptotic death signaling in healthy and cancer cells.

Authors:  Subhadip Raychaudhuri; Somkanya C Raychaudhuri
Journal:  Cells       Date:  2013-05-30       Impact factor: 6.600

Review 10.  Small molecules, big effects: the role of microRNAs in regulation of cardiomyocyte death.

Authors:  J Skommer; I Rana; F Z Marques; W Zhu; Z Du; F J Charchar
Journal:  Cell Death Dis       Date:  2014-07-17       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.